PLERIXAFOR INJECTION
Venus Remedies gets Saudi FDA approval for speciality oncology therapyVenus Remedies Limited has secured its first global marketing authorization for its specialty oncology therapy, Plerixafor, from the Saudi ...
Aurobindo Pharma arm gets USFDA nod for Plerixafor injectionAurobindo Pharma said Plerixafor injection is indicated in combination with granulocyte-colony stimulating factor (G-CSF) to mobilise hemat...
Zydus Cadila gets USFDA nod for anesthesia drugThe company has received an approval from the United States Food and Drug Administration (USFDA) to market its product in the US market, Zy...
Dr Reddy's plunges nearly 2% on patent infringement suitDr Reddy's Laboratories plunged as much as 1.85% in a weak market on Monday after Genzyme Corporation filed a suit against the company.
Genzyme Corporation files patent infringement suit against DRLMozobil (plerixafor injection) is a hematopoietic stem cell mobiliser indicated to patients with non-Hodgkin's lymphoma (blood cancer) and ...
Load More